Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
US8940293B2 · kind B2 · utility
9Cited by
15References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 2011 |
| Grant date | Jan 27, 2015 |
| Priority date | — |
| Expiry date | Jun 22, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a treatment of an autoimmune demyelinating disease/disorder. Also included in the present invention is the use of bone marrow stromal cells for the treatment of multiple sclerosis (MS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.